Chief Financial Officer at Neulogy Ventures
Check size: €200K-€3M investments, as published by Neulogy Ventures.
Martin Smetana is listed in a Chief Financial Officer capacity at Neulogy Ventures. The firm does not publish a person-specific investment thesis for this role; firm strategy is included only as shared context.
Show the technical frontier, founder insight, evidence, Slovak or CEE connection, positive impact and milestones that €200K-€3M can unlock.
Moonshot ideas that push technology, climate or health forward, led by humble and competent founders with audacious long-term ambition.
Companies without meaningful innovation, Slovak operating relevance or a fit with the firm's technology, climate and health mandate are less aligned.